GWGregory P. Walcott

Gregory P. Walcott

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gregory P. Walcott has a total of 59 co-authors. Here are the top co-authors by number of shared publications:

  • Raymond E. Ideker

    Cardiac Rhythm Management Laboratory, University of Alabama at Birmingham., Study funded by a grant from TASER International, Inc

    8 shared publications
  • Cheryl R. Killingsworth

    University of Alabama, B140 Volker Hall, 1670 University Blvd., Birmingham, AL 35294, United States

    5 shared publications
  • Jianyi Zhang

    Department of Biomedical Engineering, School of Medicine and School of Engineering, University of Alabama at Birmingham, Birmingham, AL 35294, USA

    5 shared publications
  • William M. Smith

    † Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama

    5 shared publications
  • Jack M. Rogers

    Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL 35294, USA

    4 shared publications
  • Sharon B. Melnick

    University of Alabama, B140 Volker Hall, 1670 University Blvd., Birmingham, AL 35294, United States

    4 shared publications

Latest Publications

  • Cardiomyocyte-Specific modRNA-Induced FoxM1 Overexpression Promotes Recovery From Myocardial Infarction in Adult Mammals

    by Yalin Wu, Thanh Nguyen, Yongyu Wang, Yang Zhou, Jianli Zhao, Yajing Wang, Gregory P. Walcott, Daniel J. Garry, Yuji Nakada, Jianyi Zhang


  • Follistatin From hiPSC-Cardiomyocytes Promotes Myocyte Proliferation in Pigs With Postinfarction LV Remodeling

    by Yuhua Wei, Gregory Walcott, Thanh Nguyen, Xiaoxiao Geng, Bijay Guragain, Hanyu Zhang, Akazha Green, Manuel Rosa-Garrido, Jack M. Rogers, Daniel J. Garry, et al.

    BACKGROUND: When human induced pluripotent stem cells (hiPSCs) that CCND2-OE (overexpressed cyclin-D2) were differentiated into cardiomyocytes ( CCND2-OE hiPSC-CMs) and administered to the infarcted hearts of immunodeficient mice, the cells proliferated after administration and repopulated >50% of the scar. Here, we knocked out human leukocyte antigen class I and class II expression in CCND2-OE hiPSC-CMs ( KO/OE hiPSC-CMs) to reduce the cells’ immunogenicity and then assessed the therapeutic efficacy of KO/OE hiPSC-CMs for the treatment of myocardial infarction. METHODS: KO/OE hiPSC-CM and wild-type hiPSC-CM ( WT hiPSC-CM) spheroids were differentiated in shaking flasks, purified, characterized, and intramyocardially injected into pigs after ischemia/reperfusion injury; control animals were injected with basal medium. Cardiac function was evaluated via cardiac magnetic resonance imaging, and cardiomyocyte proliferation was assessed via immunostaining and single-nucleus RNA sequencing. RESULTS: Measurements of cardiac function and scar size were significantly better in pigs treated with KO/OE hiPSC-CM spheroids than in animals treated with medium or WT hiPSC-CM spheroids. KO/OE hiPSC-CMs were detected for just 1 week after administration, but assessments of cell cycle activity and proliferation were significantly higher in the endogenous pig cardiomyocytes of the hearts from the KO/OE hiPSC-CM spheroid group than in those from the other 2 groups. Single-nucleus RNA-sequencing analysis identified a cluster of proliferating cardiomyocytes that was significantly more prevalent in the KO/OE hiPSC-CM spheroid–treated hearts (3.65%) than in the hearts from the medium (0.89%) or WT hiPSC-CM spheroid (1.33%) groups at week 1. YAP (Yes-associated protein) protein levels and nuclear localization were also significantly upregulated in pig cardiomyocytes after treatment with KO/OE hiPSC-CM spheroids. Follistatin, which interacts with the HIPPO/YAP pathway, was significantly more abundant in the medium from KO/OE hiPSC-CM spheroids than WT hiPSC-CM spheroids (30.29±2.39 versus 16.62±0.83 ng/mL, P =0.0056). Treatment with follistatin increased WT hiPSC-CM cell counts by 28.3% over 16 days in culture and promoted cardiomyocyte proliferation in the infarcted hearts of adult mice. CONCLUSIONS: KO/OE hiPSC-CM spheroids significantly improved cardiac function and reduced infarct size in pig hearts after ischemia/reperfusion injury by secreting follistatin, which upregulated HIPPO/YAP signaling and proliferation in endogenous pig cardiomyocytes.


  • Implanted Human Cardiac Spheroids Electrically Couple With Infarcted Swine Myocardium

    by Bijay Guragain, Yuhua Wei, Hanyu Zhang, Asher Kahn-Krell, Lei Ye, Gregory P. Walcott, Jack M. Rogers, Jianyi (Jay) Zhang


  • CCND2 Modified mRNA Activates Cell Cycle of Cardiomyocytes in Hearts With Myocardial Infarction in Mice and Pigs

    by Jiacheng Sun, Lu Wang, Rachel C. Matthews, Gregory P. Walcott, Yu-An Lu, Yuhua Wei, Yang Zhou, Lior Zangi, Jianyi Zhang

    BACKGROUND: Experiments in mammalian models of cardiac injury suggest that the cardiomyocyte-specific overexpression of CCND2 (cyclin D2, in humans) improves recovery from myocardial infarction (MI). The primary objective of this investigation was to demonstrate that our specific modified mRNA translation system (SMRTs) can induce CCND2 expression in cardiomyocytes and replicate the benefits observed in other studies of cardiomyocyte-specific CCND2 overexpression for myocardial repair. METHODS: The CCND2-cardiomyocyte-specific modified mRNA translation system (cardiomyocyte SMRTs) consists of 2 modRNA constructs: one codes for CCND2 and contains a binding site for L7Ae, and the other codes for L7Ae and contains recognition elements for the cardiomyocyte-specific microRNAs miR-1 and miR-208. Thus, L7Ae suppresses CCND2 translation in noncardiomyocytes but is itself suppressed by endogenous miR-1 and -208 in cardiomyocytes, thereby facilitating cardiomyocyte-specific CCND2 expression. Experiments were conducted in both mouse and pig models of MI, and control assessments were performed in animals treated with an SMRTs coding for the cardiomyocyte-specific expression of luciferase or green fluorescent protein (GFP), in animals treated with L7Ae modRNA alone or with the delivery vehicle, and in Sham-operated animals. RESULTS: CCND2 was abundantly expressed in cultured, postmitotic cardiomyocytes 2 days after transfection with the CCND2-cardiomyocyte SMRTs, and the increase was accompanied by the upregulation of markers for cell-cycle activation and proliferation (eg, Ki67 and Aurora B kinase). When the GFP-cardiomyocyte SMRTs were intramyocardially injected into infarcted mouse hearts, the GFP signal was observed in cardiomyocytes but no other cell type. In both MI models, cardiomyocyte proliferation (on day 7 and day 3 after treatment administration in mice and pigs, respectively) was significantly greater, left-ventricular ejection fractions (days 7 and 28 in mice, days 10 and 28 in pigs) were significantly higher, and infarcts (day 28 in both species) were significantly smaller in animals treated with the CCND2-cardiomyocyte SMRTs than in any other group that underwent MI induction. CONCLUSIONS: Intramyocardial injections of the CCND2-cardiomyocyte SMRTs promoted cardiomyocyte proliferation, reduced infarct size, and improved cardiac performance in small and large mammalian hearts with MI.


  • Exosomes secreted by hiPSC-derived cardiac cells improve recovery from myocardial infarction in swine

    by Ling Gao, Lu Wang, Yuhua Wei, Prasanna Krishnamurthy, Gregory P. Walcott, Philippe Menasché, Jianyi Zhang

    Cardiac cells differentiated from human induced pluripotent stem cells produce exosomes that improve recovery from myocardial infarction in pigs.


  • Ventricular fibrillation threshold of rapid short pulses

    by Gregory P. Walcott, Mark W. Kroll, Raymond E. Ideker

    The risk of VF (ventricular fibrillation) from continuous AC utility (50/60 Hz) power has been well quantified and is reflected in accepted standards. Similarly, the required charge for a single pulse delivered during the T-wave of the ECG is also quantified. However, there are no studies that deal with the VF risk of a train of multiple short pulses such as those used in electric fences and conducted electrical weapons (CEWs). We studied 5 swine with an electrode placed through the anterior chest such that the tip was 10 mm from the epicardium. A return electrode was attached remotely to the lower abdomen. Five-second trains of 100 μs pulses at rates of 10–70 PPS (pulses per second) were delivered with gradually increasing charges until VF was induced. The VF threshold was also determined for 60 Hz AC current. As expected, the VF charge threshold decreased with increasing rates. For pulse rates between 10–30 PPS, the aggregate current (= charge • pulse rate) was constant at the VF threshold. The VF threshold in terms of AC RMS current was 7.4 ± 1.9 times the aggregate current VF threshold for the rapid short pulses. These results may have utility for setting safety standards for electric fences and for CEWs such as TASER® CEWs. This also allows for the risk assessment of CEWs by comparison to international electrical safety standards. The output of these weapons appears to be well below the VF risk limits as set by these standards.


  • Open Access

    Effect of timing and duration of a single chest compression pause on short-term survival following prolonged ventricular fibrillation

    by Gregory P. Walcott, Sharon B. Melnick, Robert G. Walker, Isabelle Banville, Fred W. Chapman, Cheryl R. Killingsworth, Raymond E. Ideker


  • Transmural recording of shock potential gradient fields, early postshock activations, and refibrillation episodes associated with external defibrillation of long-duration ventricular fibrillation in swine

    by James D. Allred, Cheryl R. Killingsworth, J. Scott Allison, Derek J. Dosdall, Sharon B. Melnick, William M. Smith, Raymond E. Ideker, Gregory P. Walcott


  • Do clinically relevant transthoracic defibrillation energies cause myocardial damage and dysfunction?

    by Gregory P. Walcott, Cheryl R. Killingsworth, Raymond E. Ideker


  • Effects of burst stimulation during ventricular fibrillation on cardiac function after defibrillation

    by Gregory P. Walcott, Sharon B. Melnick, Cheryl R. Killingsworth, William M. Smith, Raymond E. Ideker

    The purpose of defibrillation is to rapidly restore blood flow and tissue perfusion following ventricular fibrillation (VF) and shock delivery. We tested the hypotheses that 1) a series of 1-ms pulses of various amplitudes delivered before the defibrillation shock can improve hemodynamics following the shock, and 2) this hemodynamic improvement is due to stimulation of cardiac or thoracic sympathetic nerves. Ten anesthetized pigs received a burst of either 15 or 30 1-ms pulses (0.1–10 A in strength) during VF, after which defibrillation was performed. ECG, arterial blood pressure, and left ventricular (LV) pressure were recorded. Defibrillation shocks and burst pulses were delivered from a right ventricular coil electrode to superior vena cava coil and left chest wall electrodes. Sympathetic blockade was induced with 1 mg/kg timolol and trials were repeated. The first half of this protocol was repeated in two animals that were pretreated with reserpine. Heart rate (HR) after 1-, 2-, 5-, and 10-A pulses was significantly higher than after control shocks without preceding pulse therapy. Mean and peak LV pressure measurements increased 38 and 72%, respectively, following shocks preceded by 5- and 10-A pulses compared with shocks preceded by no burst pulses. Mean and peak arterial pressures increased 36 and 43%, respectively, following shocks preceded by 5- and 10-A pulses compared with shocks preceded by no burst pulses. After β-blockade, HR, mean and peak arterial pressures, and mean LV pressure were not significantly different after pulses of any strength compared with control shocks. LV peak pressure following the 10-A pulses was significantly higher than with no burst pulses but was significantly lower than the response to the 10-A pulses delivered without β-blockade. HR, mean and peak arterial pressures, and mean and peak LV pressure responses after 15 or 30 5- or 10-A pulses were similar to the responses to the same pulses after β-blockade. We conclude that a burst of 15–30 1-ms pulses delivered during VF can increase HR, arterial pressure, and LV pressure following defibrillation. β-Blockade or reserpine pretreatment prevents most of this postshock increase in HR, arterial pressure, and LV pressure.